RC198

RC198 · RemeGen Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RC198, covering 2024-08-16 to 2024-08-16. Get the full timeline:

Most recent: Clinical Trial Update: A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors [Phase 1]